по- често при рамото на комбинирана терапия (Trudexa / метотрексат) в сравнение с рамото на ст
tho rheumatoid arthritis (disease duration of less than 3 years) (Study V), elevations of ALT were more common in the combination arm (Trudexa / methotrexate) compared to the methotrexate monotherapy arm or the Trudexa monotherapy arm.